Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) Enterprise Value (2022 - 2025)

Praxis Precision Medicines has reported Enterprise Value over the past 4 years, most recently at -$599.3 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$599.3 million for Q4 2025, down 52.67% from a year ago — trailing twelve months through Dec 2025 was -$599.3 million (down 52.67% YoY), and the annual figure for FY2025 was -$599.3 million, down 52.67%.
  • Enterprise Value for Q4 2025 was -$599.3 million at Praxis Precision Medicines, down from -$267.2 million in the prior quarter.
  • Over the last five years, Enterprise Value for PRAX hit a ceiling of -$56.0 million in Q2 2022 and a floor of -$599.3 million in Q4 2025.
  • Median Enterprise Value over the past 4 years was -$165.9 million (2023), compared with a mean of -$215.6 million.
  • Biggest five-year swings in Enterprise Value: plummeted 382.86% in 2024 and later grew 25.17% in 2025.
  • Praxis Precision Medicines' Enterprise Value stood at -$61.6 million in 2022, then plummeted by 31.95% to -$81.3 million in 2023, then crashed by 382.86% to -$392.6 million in 2024, then tumbled by 52.67% to -$599.3 million in 2025.
  • The last three reported values for Enterprise Value were -$599.3 million (Q4 2025), -$267.2 million (Q3 2025), and -$301.3 million (Q2 2025) per Business Quant data.